Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Total revenue	$ 10	$ 14	$ 35	$ 93
Cost of sales	70		70
Gross profit	(60)	14	(35)	93
Operating expenses:
Research and development	283	558	925	2,160
Management contingent share plan expense (forfeitures)	(1,553)		(141)
Impairment of intangible assets and cloud computing arrangements			2,633
Selling, general and administrative	4,717	8,269	15,052	17,239
Total operating expenses	3,447	8,827	18,469	19,399
Loss from operations	(3,507)	(8,813)	(18,504)	(19,306)
Non-cash change in fair value of convertible debentures		(3,697)		(28,180)
Change in fair value of warrant liability	36	1,349	244	1,349
Change in fair value of forward purchase put derivative		(1,284)		(1,284)
Change in fair value of forward purchase collateral derivative		(27,378)		(27,378)
Loss from PIK Note Amendment and 2022 Debenture Release			(3,521)
Interest expense	(148)	(424)	(865)	(1,250)
Other income (expense)	(41)	(779)	54	(883)
Total non-operating expense	(153)	(32,213)	(4,088)	(57,626)
Loss before income taxes	(3,660)	(41,026)	(22,592)	(76,932)
Provision for income taxes
Net loss	(3,660)	(41,026)	(22,592)	(76,932)
Deemed dividends related to the Exchange Offer and trigger of down round provisions of Assumed Warrants	(912)		(3,378)
Net loss to common stockholders	$ (4,572)	$ (41,026)	$ (25,970)	$ (76,932)
Class A Common Stock
Operating expenses:
Net loss per share of Class A common stock, basic (in Dollars per share)	$ (0.94)	$ (67.04)	$ (7.75)	$ (128.65)